Situation as a whole in my opinion:
Long term investors
Situation as a whole in my opinion:
Long term investors are accumulating mediocre share amounts at Stink bids in the low .$50's which is supporting share price organically.
MM's are utilizing penny day traders and volume to make money in the spread as they trade securities to the big guys. They hedge long and short and if the securities do not exist they then Naked Short. This is why we see volume and price increase EVERY Friday. They need to be liquid in case news comes Monday morning as expected in order to not be caught with their pants down and be able to handle the volume expected to trade after news.
Mostly Bashers, and also Pumpers, are utilized on a daily basis on boards to help MM's maintain ask/bid price both up and down to clear out their positions while wholesaling the securities.
Aspire is holding most if not all shares, or selling only to the means of keeping share price over $.50 to adhere to the terms of their current agreement. They have pre-funded warrants that can be executed to make sure they do not have to file as an affiliate while they wait for the news to come.
CDA's and normal public company guidelines have given the right and authority for IPIX to withhold any and all information they have in regards to BTD, Prurisol results (if End Points are met), negotiations, partnerships and buyout offers.
IPIX does not need to release information UNLESS it will directly affect share price due to the information being obtained by non-insiders with potential to trade or utilize for financial gain without public knowledge. They will need to report Prurisol results in a timely manner if End Points are not met.
IPIX has created a Milestone based agreement for funding as well as multiple manufacturing and distribution agreements for B-OM to be manufactured for Phase 3 and beyond. This HAS BEEN DONE for two reasons only. Partnering and/or Buyout Pharma has stipulated this in their agreement and/or the Aspire agreement and manufacturing agreement to "go at it alone" gives a negotiating tool for increased evaluation to the company as a whole.
I commend management!
Depending on internal events we are not privy to, we will see BTD determination and/or Pruisol results first. The order depends...
BTD may have already been approved but IPIX can withhold this information. Prurisol results are known internally or will be known soon...
If Prurisol results are extraordinary then we will hear this announced, then BTD designation, then buyout (maybe all at once). This could come anytime which should scare anyone short.
If Prurisol results are not up to the Buyout Pharma's standards then we will hear Top Line Results, BTD determination followed by a partnership for B-OM. In this scenario the partnership up-front payments will be utilized to further B franchise, Prurisol reformulation for other uses like topical cream for itching, and K's additional phasing.
The longer Prurisol results take to come out the more and more excited I become. IPIX can withhold great results unless it's leaked but must report in a timely fashion if results do not meet their end points.
Stay the Course, Add on the dips, Remove the trash talk from your head to make educated rational decisions.
Good luck All!
11
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dispatch from the Digital Trenches GreenCore Solutions Corp. (GSC) just made a bit of a splash with those numbers any company would salivate over. We're talking 24.5 million AI agent transactions in just one month. If that doesn't jolt your morning coffee, not sure what will. AI Agents Getting Busy For those out of the loop, GSC isn't your run-of-the-mill tech outfit....
Continue Reading
Tech Job Growth Defies Corporate Layoffs Job markets in the tech world are hotter than a two-dollar pistol. Despite seeing some layoffs in tech firms, the demand for skilled tech workers is still booming. You got tech companies tightening the bolts, laying off around 14,700 folks, but here's the kicker: overall tech employment shot up with 86,000 new jobs in August....
Continue Reading
PerfectVape's Digital Bargain Bonanza Alright, so you think you've seen savings? Well, PerfectVape's throwing a real bone to those hunting for vape deals online. They're slapping 10% off on select disposable vapes—no strings, just a promo code, PV10, you punch in at checkout. We've got ourselves an internet-era sale without needing to elbow through crowds. Browsing Made...
Continue Reading
Here's the move: Primero Games, the U.S.-based gaming maestro, just grabbed a hefty piece of the puzzle with their acquisition of Win Systems' Gaming Division. Not two companies merging into obscurity, but a strategic maneuver aiming to scatter new seeds in Latin America and the Caribbean with over 3,000 gaming positions primed and ready. What's in the Pot? You've got...
Continue Reading
FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...
Continue Reading
Celebrating 18 Years: A Journey of Comfort It's not often you see a business weave itself so seamlessly into the fabric of its community. But that's exactly what Luxury Air A/C & Heating has done in Conroe, The Woodlands, and across Montgomery County. Hit 18 years in the HVAC game, and you've clearly nailed something other folks can't quite replicate. Guess there's no...
Continue Reading
FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...
Continue Reading
A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...
Continue Reading
Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...
Continue Reading
When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...
Continue Reading
Top 5 Most Recently Viewed Articles
FIRSTHABIT Concludes the CHALK AI Math Challenge with Enthusiastic Participation At the recent CES 2026, a global technology showcase, FIRSTHABIT marked a remarkable achievement by successfully conducting the CHALK AI Math Challenge, drawing in participants eager to engage with innovative learning tools. This event, held in a vibrant setting at Eureka Park within the...
Continue Reading
Understanding the Tesla Class Action Lawsuit Tesla, Inc. has come under scrutiny with a recent class action lawsuit that could impact many investors. This case primarily involves individuals who purchased Tesla securities during the specified class period. Investors are seeking to recover their losses related to misleading statements made by the company regarding its...
Continue Reading
Innovative Leadership at DNA Nanobots DNA Nanobots, a pioneering biotechnology firm centered on the development of DNA nanoparticles for targeted therapeutic solutions, is thrilled to announce the addition of Dr. John C. Byrd, M.D. to its Scientific Advisory Board (SAB). Known for his substantial contributions to the field of blood cell cancer therapies, Dr. Byrd's...
Continue Reading
Market Reactions to Political Events Recently, there has been significant activity in the stock market following political announcements. A recent framework discussion regarding Greenland led to a surprising impact on stocks. This event sparked an immediate relief rally in which major indexes ended the day up by over 1%. The Russell 2000 index, a benchmark for small-cap...
Continue Reading
ARTHEx Biotech Secures $87 Million to Propel RNA Medicines Forward ARTHEx Biotech S.L., a cutting-edge biotechnology company that is at the forefront of developing targeted RNA medicines, has achieved a significant milestone by successfully closing its upsized Series B financing. This funding round, which now totals $87 million, was primarily led by Bpifrance, a new...
Continue Reading